1:47 The NETSseq platform: identifying novel targets for the treatment of Parkinson's disease 4:36 The infusON trial: continuous, subcutaneous apomorphine for PD motor fluctuations 1:11 le succès continu de notre patiente géorgienne avec la stimulation cérébrale profonde ! 3:18 Schizophrénie symptômes, causes et traitements 0:51 Defining Metabolic Health: Function Over Flawless